Massachusetts General Hospital
Mon Jun 24, 2019 on Facebook
A team led by scientists from the Broad Institute of MIT and Harvard's Cancer Program and the Massachusetts General Hospital Cancer Center has created a powerful new approach that detects mutations across many different types of normal cells by analyzing RNA (ribonucleic acid that’s present in all living cells) sequencing data from normal tissues. “It’s not easy to identify mutations from RNA, because there's a lot of ‘noise’ in RNA data, and all our tools have been developed and tuned for calling mutations in DNA,” said Mass General Cancer Center's Gad Getz, senior author on the paper.